CGEM
Price
$7.77
Change
+$0.10 (+1.30%)
Updated
Jul 17, 04:59 PM (EDT)
Capitalization
458.54M
20 days until earnings call
DNLI
Price
$14.53
Change
-$0.34 (-2.29%)
Updated
Jul 17 closing price
Capitalization
2.11B
13 days until earnings call
Interact to see
Advertisement

CGEM vs DNLI

Header iconCGEM vs DNLI Comparison
Open Charts CGEM vs DNLIBanner chart's image
Cullinan Therapeutics
Price$7.77
Change+$0.10 (+1.30%)
Volume$3.63K
Capitalization458.54M
Denali Therapeutics
Price$14.53
Change-$0.34 (-2.29%)
Volume$1.03M
Capitalization2.11B
CGEM vs DNLI Comparison Chart in %
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. DNLI commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Hold and DNLI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (CGEM: $7.77 vs. DNLI: $14.53)
Brand notoriety: CGEM and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 73% vs. DNLI: 69%
Market capitalization -- CGEM: $458.54M vs. DNLI: $2.11B
CGEM [@Biotechnology] is valued at $458.54M. DNLI’s [@Biotechnology] market capitalization is $2.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEM is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 4 TA indicator(s) are bullish while DNLI’s TA Score has 4 bullish TA indicator(s).

  • CGEM’s TA Score: 4 bullish, 4 bearish.
  • DNLI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CGEM and DNLI are a good buy in the short-term.

Price Growth

CGEM (@Biotechnology) experienced а -0.89% price change this week, while DNLI (@Biotechnology) price change was -5.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.06%. For the same industry, the average monthly price growth was +13.62%, and the average quarterly price growth was +40.41%.

Reported Earning Dates

CGEM is expected to report earnings on Nov 06, 2025.

DNLI is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.11B) has a higher market cap than CGEM($459M). DNLI YTD gains are higher at: -28.705 vs. CGEM (-36.207). CGEM has higher annual earnings (EBITDA): -208.62M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. CGEM (304M). CGEM has less debt than DNLI: CGEM (1.84M) vs DNLI (48.6M). CGEM (0) and DNLI (0) have equivalent revenues.
CGEMDNLICGEM / DNLI
Capitalization459M2.11B22%
EBITDA-208.62M-505.16M41%
Gain YTD-36.207-28.705126%
P/E RatioN/AN/A-
Revenue00-
Total Cash304M818M37%
Total Debt1.84M48.6M4%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMDNLI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 11 days ago
80%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CRMAX10.04N/A
N/A
CRM Small/Mid Cap Value Inv
LAIDX9.34N/A
N/A
Lord Abbett International Value I
FSNIX16.68N/A
N/A
Fidelity Advisor Asset Manager 60% I
SFAAX39.83N/A
N/A
Allspring Index Asset Allocation A
PEVAX15.95N/A
N/A
PACE Small/Medium Co Value Equity A

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
+1.30%
IDYA - CGEM
52%
Loosely correlated
-0.27%
MDGL - CGEM
50%
Loosely correlated
+1.09%
DNLI - CGEM
49%
Loosely correlated
-2.29%
BEAM - CGEM
48%
Loosely correlated
+1.89%
ATXS - CGEM
48%
Loosely correlated
-1.42%
More